Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.60 |
| ▸ | CA2 | P00918 | 1/20 | 0.60 |
| ▸ | SIRT2 | Q8IXJ6 | 2/20 | 0.57 |
| ▸ | SIRT1 | Q96EB6 | 2/20 | 0.57 |
| ▸ | SIRT3 | Q9NTG7 | 1/20 | 0.57 |
| ▸ | FOLH1 | Q04609 | 4/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
| ▸ | MMP9 | P14780 | 1/20 | 0.48 |
| ▸ | CPB1 | P15086 | 1/20 | 0.48 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30823334 | 0.94 | FOLH1 (0.64) | CA1CA2SIRT2SIRT1SIRT3 | |
| SCHEMBL27136756 | 0.93 | FOLH1 (0.53) | CA1CA2SIRT2SIRT1SIRT3 | |
| SCHEMBL29072142 | 0.89 | CA1 (0.64) | CA1CA2SIRT2SIRT1SIRT3 | |
| SCHEMBL29072091 | 0.89 | CA1 (0.64) | CA1CA2SIRT2SIRT1SIRT3 | |
| SCHEMBL29326176 | 0.85 | CA1 (0.60) | CA1CA2SIRT2SIRT1SIRT3 | |
| SCHEMBL14642785 | 0.85 | SIRT2 (0.57) | SIRT2SIRT1SIRT3FOLH1PTGER4 | |
| SCHEMBL26241560 | 0.84 | KLK7 (0.54) | SIRT2SIRT1SIRT3FOLH1 | |
| SCHEMBL31298691 | 0.84 | KLK7 (0.56) | FOLH1LMNASMN1; SMN2 | |
| SCHEMBL18348898 | 0.84 | SIRT2 (0.72) | CA1CA2SIRT2SIRT1SIRT3 | |
| SCHEMBL15976615 | 0.83 | CA1 (0.66) | CA1CA2SIRT2SIRT1SIRT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4577526-A1 | VHH ANTIBODY CONJUGATES | Abdera Therapeutics Inc. (US) | 2025-07-02 | — | — | EP | disclosed |
| WO-2024044549-A1 | VHH ANTIBODY CONJUGATES | Abdera Therapeutics Inc. (US) | 2024-02-29 | — | — | WO | disclosed |